From our Center

Articles, News, Press Releases

Summer 2020

Wall Center contributes to Consortium Research

Congratulations to current (Mark A. Krasnow, MD, PhD, Christin S. Kuo, MD, Maya Kumar, PhD, Ross Metzger, PhD, F. Hernán Espinoza, PhD, Astrid Gillich, PhD, Kyle J. Travaglini, Fan Zhang) and past (Douglas Brownfield, PhD, Ahmad N. Nabhan, PhD) Wall Center faculty, staff, and affiliates that are part of the Tabula Muris Consortium on their recent publications in Nature 'A single-cell transcriptomic atlas characterizes ageing tissues in the mouse' and 'Ageing hallmarks exhibit organ-specific temporal signatures'.  


François Haddad, MD

Congratulations Dr. François Haddad!

The Wall Center congratulates François Haddad, MD, on being appointed as Clinical Professor of Medicine in Cardiovascular Medicine. Dr. Haddad specializes in the field of cardio-vascular imaging, pulmonary hypertension, advanced heart failure and transplantation. Dr. Haddad has over 18 years of experience in the field of cardiology. He directs the Stanford Cardiovascular Institute Clinical Biomarker and Phenotype Core Laboratory (BPCL), dedicated to translational studies in cardiovascular medicine.

Please join us in congratulating Dr. Haddad on this accomplishment!


Ryan Anderson, MD, Kristina Kudelko, MD, & Roberto J. Bernardo, MD, MS

Congratulations 2020 Clinical PH Fellows

The Wall Center congratulates Dr. Roberto J. Bernardo, MD, MS, 2019-2020 eBay Fellow in Pulmonary Vascular Disease and Ryan Anderson, MD, 2019-2020 Pulmonary & Critical Care Fellow on an unforgettable year of training.

The Vera Moulton Wall Center fellowship program is headed by, Kristina Kudelko, MD, Clinical Associate Professor
Division of Pulmonary, Allergy and Critical Care Medicine and Director of Education, Vera Moulton Wall Center.


Andrew Sweatt, MD

Congratulations to Dr. Sweatt, new recipient of an NIH K23 Award!

Andrew Sweatt, MD, Clinical Assistant Professor in the Division of Pulmonary, Allergy and Critical Care Medicine recently authored an already highly-cited Circulation Research study which effectively illustrates how machine-learning approaches can be used to organized complicated data sets (in this case, inflammatory biomarkers) to classify pulmonary hypertension phenotypes in an unprecedented manner. By using artificial intelligence methodologies, new discoveries are rapidly being made, and Stanford, a pioneering site for the development of this field.

For this training award, Roham Zamanian, MD, FCCP, Associate Professor in the Division of Pulmonary, Allergy and Critical Care Medicine and Director of the Adult Pulmonary Hypertension Program will be serving as his mentor.  

Subscribe to our eNews

Winter 2019 / Spring 2020


Vinicio de Jesus Perez, MD and Roham Zamanian, MD, FCCP

Congratulations to Vinicio de Jesus Perez and Roham Zamanian for a High Impact COVID-19 Story

Roham Zamanian, MD, FCCP, Associate Professor in the Division of Pulmonary, Allergy and Critical Care Medicine and Director of the Adult Pulmonary Hypertension Program and Vinicio de Jesus Perez, MD, Associate Professor of Medicine in Pulmonary, Allergy, and Critical Care Medicine, along with other distinguished colleagues, published their fascinating case report in the American Journal of Respiratory and Critical Care Medicine detailing the outpatient management of a patient with concomitant idiopathic pulmonary arterial hypertension (iPAH) and COVID-19 disease using inhaled nitric oxide (iNO).


Myriam Amsallem, MD, PhD

Congratulations Dr. Amsallem!

Myriam Amsallem, MD, PhD, Instructor of Medicine in the Division of Cardiovascular Medicine and member of the Vera Moulton Wall Center, recently published “Quantifying the Influence of Wedge Pressure, Age, and Heart Rate on the Systolic Thresholds for Detection of Pulmonary Hypertension” in the Journal of the American Heart Association. This invasive study supports lower systolic pulmonary arterial pressure thresholds for pulmonary hypertension diagnosis in patients with higher pulmonary artery wedge pressure (such as patients with left-sided heart failure), which has a direct implication for imrpoving the detection of pulmonary hypertension.

Kristina Kudelko, MD

What our Pulmonary Hypertension (PH) Patients Should Know About COVID-19

Kristina Kudelko, MD, Clinical Associate Professor in the Division of Pulmonary, Allergy and Critical Care Medicine shares important information regarding pulmonary hypertension and COVID-19.


Roham Zamanian, MD, FCCP

Care of patients with Pulmonary Arterial Hypertension during the Coronavirus (COVID-19) Pandemic  

Roham Zamanian, MD, FCCP, Associate Professor in the Division of Pulmonary, Allergy and Critical Care Medicine and Director of the Adult Pulmonary Hypertension Program, along with leading pulmonary hypertension clinicians published an express manuscript about caring for PH patients with COVID-19.

 More 

Abstract: The COVID-19 pandemic presents many unique challenges when caring for patients with pulmonary hypertension (PH).The COVID-19 pandemic has altered routine standard of care practice and the acute management particularly for those patients with pulmonary arterial hypertension (PAH), where PAH-specific treatments are used. It is important to balance the ongoing care andevaluation of PAH patients with “exposure risk” to COVID-19 for patients coming to clinic or the hospital. If there is a morbidity and mortality benefit from starting PAH therapies, for example in a patient with high-likelihood of PAH, then it remains important to complete the thorough evaluation. However, the COVID-19 outbreak may also represent a unique time when PH experts have to weigh the risks and benefits of the diagnostic work-up including potential exposure to COVID-19 versus initiatingtargeted PAH therapy in a select high-risk, highlikelihood World Symposium Pulmonary Hypertension (WSPH) Group 1 PAH patients.This document will highlight some of the issues facing providers, patients and the PAH community in real-time as the COVID-19 pandemic isevolving and is intended to share expected common clinical scenarios and best clinical practices to help the community at-large.

 Less 

Roham Zamanian, MD, FCCP

Special Edition phaware® Podcast with Dr. Roham Zamanian  

Our friends at phaware® shared a special edition podcast with Roham Zamanian, MD, FCCP, Associate Professor in the Division of Pulmonary, Allergy and Critical Care Medicine and Director of the Adult Pulmonary Hypertension Program,  discussing the coronavirus (COVID-19) and gives specific advice for the PH Community.


Jonah, Paige, and Oliver presenting the Splash Bag for Paige's PH pump at the Science and Engineering Expo at Oliver and Jonah's elementary school.

Elementary School Students Change the World, One PH pump at a Time

Recently, we received the following inquiry to borrow a CADD MS3 pump, the device used to administer continuous subcutaneous infusion of prostacyclin medication:


Edda Spiekerkoetter, MD

Congratulations Dr. Edda Spiekerkoetter and the HHT Team

The Wall Center congratulates Edda Spiekerkoetter, MD, Associate Professor of Medicine in Pulmonary, Allergy, and Critical Care Medicine, Co-chair of the Research Subcommittee at the Vera Moulton Wall Center and Director of the recently designated Hereditary Hemorrhagic Telangiectasia (HHT) Center of Excellence at Stanford Health Care. HHT, is a little-known disorder causing malformed blood vessels that can affect the skin and other organs.


Yon Sung, MD

Congratulations Dr. Yon Sung!

The Wall Center congratulates Yon Sung, MD, Associate Professor of Medicine in Pulmonary, Allergy and Critical Care Medicine and Director of Community Outreach for the Vera Moulton Wall Center Education Subcommittee, winner of the 2020 Teaching Award for the Division of Pulmonary, Allergy and Critical Care Medicine.

Past News